The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Feeling hot 41
SANDOSTATIN LAR DEPOT Frequent bowel movements 41
SANDOSTATIN Abdominal pain 40
SANDOSTATIN LAR DEPOT Hypoglycaemia 40
SANDOSTATIN LAR DEPOT Blood growth hormone increased 39
SANDOSTATIN LAR DEPOT Burning sensation 39
SANDOSTATIN LAR DEPOT Confusional state 39
SANDOSTATIN Asthenia 38
SANDOSTATIN LAR DEPOT Pollakiuria 38
SANDOSTATIN Dyspnoea 37
SANDOSTATIN LAR DEPOT Muscular weakness 37
SANDOSTATIN LAR DEPOT Somnolence 36
SANDOSTATIN LAR DEPOT Arthritis 35
SANDOSTATIN LAR DEPOT Chest discomfort 35
SANDOSTATIN Pain 34
SANDOSTATIN LAR DEPOT Dyspepsia 34
SANDOSTATIN LAR DEPOT Hypersomnia 34
SANDOSTATIN LAR DEPOT Infection 34
SANDOSTATIN LAR DEPOT Insulin-like growth factor increased 34
SANDOSTATIN LAR DEPOT Skin discolouration 34

Total Records: 2,045     Number of Pages: 103